Purchase Order 75N93023P01095
Award Date
8/31/23
Potential Completion Date
10/31/23
Potential Value
$121K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Charles River Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Charles River Laboratories, Inc. was awarded a firm fixed price delivery order valued at four hundred fifty-two thousand eight hundred nine dollars and eighty cents ($452,809.80) by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Charles River to manufacture clinical trial material for respiratory syncytial virus vaccine candidates known as B/HPIV3/HMPV-F under lots PIV#115A and PIV#116. Performance will occur in Wilmington,...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...
This $186,389.10 firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract, which does not have a set-aside designation, was awarded on February 10, 2015 with an ultimate completion date of August 9, 2016. Charles River Laboratories is a global contract research organization...
This is a $525,975.60 firm-fixed-price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the provision of clinical trial materials for virus vaccines. The contract has a completion date of December 31, 2024 and was not set aside for any specific business type. Charles River Laboratories is a global provider of essential products and services to support drug discovery,...
This federal contract award, valued at $164,622.60, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract is a delivery order with a firm fixed price. Charles River Laboratories is a global contract research organization that provides a wide range of research-related products and services to government agencies, including laboratory animals, diagnostic...
This is a $184,775.40 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract has an ultimate completion date of December 31, 2014 and does not have a set-aside designation. Charles River Laboratories is a global contract research organization that provides specialized products and services to support government...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $135,865.00 firm fixed-price purchase order to Charles River Laboratories, Inc. (doing business as Charles River) to manufacture and characterize Pichia working and master cell banks. This contract is not associated with any set-aside designation. Charles River is a contract research company that provides products and services to support pharmaceutical and...
This is a federal contract award to Charles River Laboratories, Inc. (Charles River) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $187,327.80 firm fixed-price contract is for the manufacture and safety testing of experimental virus vaccines. The contract does not have a set-aside designation. Charles River is a leading provider of research products and services to government agencies, including laboratory...
<p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $403,774.50 firm fixed price delivery order contract to Charles River Laboratories, Inc., doing business as Charles River, for coronavirus challenge virus support. The contract will be performed in Wilmington, Massachusetts over a one year period from July 25, 2022 through July 24, 2023. No subcontractors were identified.</p>
This is a Firm Fixed Price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $188,452.80 and a completion date of September 17, 2015. This contract does not have a set-aside designation. Charles River Laboratories is a global contract research organization that provides a wide range of research-related products...